Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A monoclonal antibody over monalizumab for the treatment of cancer

Abstract A semimechanistic pharmacokinetic (PK)/receptor occupancy (RO) model was constructed to differentiate a next generation anti‐NKG2A monoclonal antibody (KSQ mAb) from monalizumab, an immune checkpoint inhibitor in multiple clinical trials for the treatment of solid tumors. A three‐compartmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Phillip Spinosa (Author), Monika Musial‐Siwek (Author), Marc Presler (Author), Alison Betts (Author), Emily Rosentrater (Author), Janice Villali (Author), Lucia Wille (Author), Yang Zhao (Author), Tom McCaughtry (Author), Kalyanasundaram Subramanian (Author), Hanlan Liu (Author)
Formato: Livro
Publicado em: Wiley, 2021-03-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível